Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
Nonalcoholic fatty liver disease (NAFLD), its more rapidly progressive steatohepatitic variant [nonalcoholic steatohepatitis, (NASH)], and the recently defined metabolic dysfunction-associated fatty liver disease (MAFLD) may be collectively alluded to as “metabolic fatty liver syndromes” (MFLS). MFL...
Saved in:
Main Author: | Amedeo Lonardo |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2023-08-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100816/100816.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperferritinemia at the patient with chronic hepatitis C
by: Ye. N. German, et al.
Published: (2009-02-01) -
Study of vascular endothelial dysfunction in children with beta-thalassemia major before and after quercetin therapy
by: Fatma Al Zahraa Sherai, et al.
Published: (2025-02-01) -
Primary Terminal Haemochromatosis in a 50 Year-Old Patient
by: M. I. Gonik, et al.
Published: (2021-04-01) -
Heme-Iron OptiFer® in the Treatment of Iron Deficiency Anemia During Pregnancy
by: Ibrahim A. Abdelazim, et al.
Published: (2022-03-01) -
Effect of probiotic and prebiotics supplementation on hemoglobin levels and iron absorption among women of reproductive age and children: a systematic review and meta-analysis
by: Aditi Apte, et al.
Published: (2025-02-01)